MedTrace Logo

Effectiveness of tDCS for the Treatment of Functional Dyspepsia

NCT02611414 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2016-05-19

No results posted yet for this study

Summary

Functional dyspepsia is a very common disorder of great challenge to clinical management. A therapeutic targets is up-regulation of visceral pain threshold. The transcranial direct current stimulation (tDCS) is a novel therapy that pursues these properties, besides its safety and easy adherence. There is a great need of new treatments for functional dyspepsia. There is no current study evaluating tDCS for this disease.

Conditions

  • Dyspepsia

Interventions

DEVICE

anodal tDCS

tDCS anodal stimulation over M1 area applied for 20 minutes at five consecutive days.

DEVICE

Sham tDCS

tDCS sham stimulation over M1 applied for 20 minutes (with current turned off at 30 seconds) at five consecutive days.

Sponsors & Collaborators

  • Hospital Ernesto Dornelles

    lead OTHER

Principal Investigators

  • Guilherme B Sander, PhD · Endoscopy and Gastroenterology Unit Coordinator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-01-31
Completion
2020-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02611414 on ClinicalTrials.gov